| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8295164 | Biochemical and Biophysical Research Communications | 2018 | 28 Pages |
Abstract
This study shows that metformin can attenuate activation of HSCs by activating the AMPK pathway and inhibiting the succinate-GPR91 pathway. Metformin has therapeutic potential for treating steatohepatitis and liver fibrosis.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Giang Nguyen, So Young Park, Cong Thuc Le, Won Sun Park, Dae Hee Choi, Eun-Hee Cho,